| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
18,740,000 |
| Market
Cap: |
45.35(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.53 - $4.4 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 5.8 |
| Insider 3/6 Months : 6.4 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile DiaMedica Therapeutics is a biopharmaceutical company engaged in developing novel therapeutic products to improve the lives of people with Type 1 diabetes, Type 2 diabetes and other significant diseases with unmet medical needs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
20,000 |
1,667,889 |
5,405,460 |
| Total Buy Value |
$0 |
$49,200 |
$5,742,445 |
$10,565,177 |
| Total People Bought |
0 |
1 |
7 |
8 |
| Total Buy Transactions |
0 |
1 |
8 |
21 |
| Total Shares Sold |
0 |
0 |
0 |
2,855,847 |
| Total Sell Value |
$0 |
$0 |
$0 |
$3,526,971 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pilnik Richard D. |
Director |
– • – |
2024-01-02 |
4 |
A |
$2.80 |
$85,000 |
D/D |
30,357 |
278,602 |
|
- |
|
| Giuffre Randall Michael |
Director |
– • – |
2024-01-02 |
4 |
A |
$2.80 |
$53,749 |
D/D |
19,196 |
364,551 |
|
- |
|
| Parsons James T. |
Director |
– • – |
2024-01-02 |
4 |
A |
$2.80 |
$59,998 |
D/D |
21,428 |
59,937 |
|
- |
|
| Semba Charles Pauling |
Director |
– • – |
2024-01-02 |
4 |
A |
$2.80 |
$26,250 |
D/D |
9,375 |
39,318 |
|
- |
|
| Kuntz Richard |
Director |
– • – |
2024-01-02 |
4 |
A |
$2.80 |
$39,998 |
D/D |
14,285 |
14,285 |
|
- |
|
| Wambeke David J. |
Chief Business Officer |
• – – |
2023-11-16 |
4 |
B |
$2.46 |
$49,200 |
D/D |
20,000 |
527,114 |
2.74 |
16% |
|
| Tomeqt Private Ab |
10% Owner |
– – • |
2023-06-23 |
4 |
B |
$3.40 |
$4,999,999 |
I/I |
1,470,588 |
4,326,435 |
1.5 |
-49% |
|
| Pauls Dietrich John |
President and CEO |
• • – |
2023-06-23 |
4 |
B |
$3.91 |
$49,997 |
D/D |
12,787 |
68,591 |
2.81 |
-49% |
|
| Wambeke David J. |
Chief Business Officer |
• – – |
2023-06-23 |
4 |
B |
$3.91 |
$150,003 |
D/D |
38,364 |
507,114 |
2.74 |
-49% |
|
| Kellen Scott |
CFO and Secretary |
• – – |
2023-06-23 |
4 |
B |
$3.91 |
$39,100 |
D/D |
10,000 |
32,290 |
2.74 |
-49% |
|
| Pilnik Richard D. |
Director |
– • – |
2023-06-23 |
4 |
B |
$3.91 |
$149,999 |
D/D |
38,363 |
248,245 |
2.39 |
-49% |
|
| Giuffre Randall Michael |
Director |
– • – |
2023-06-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,000 |
345,355 |
|
- |
|
| Giuffre Randall Michael |
Director |
– • – |
2023-06-23 |
4 |
B |
$3.91 |
$254,150 |
D/D |
65,000 |
360,355 |
2.39 |
-49% |
|
| Semba Charles Pauling |
Director |
– • – |
2023-06-23 |
4 |
B |
$3.91 |
$49,997 |
D/D |
12,787 |
29,943 |
2.39 |
-49% |
|
| Jacinto Richard Ii |
|
– – • |
2023-06-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,558,823 |
|
-49% |
|
| Wambeke David J. |
Chief Business Officer |
• – – |
2023-04-10 |
4 |
B |
$1.60 |
$750,000 |
D/D |
468,750 |
468,750 |
2.74 |
81% |
|
| Giuffre Randall Michael |
Director |
– • – |
2023-01-03 |
4 |
A |
$1.53 |
$53,749 |
D/D |
35,130 |
295,355 |
|
- |
|
| Semba Charles Pauling |
Director |
– • – |
2023-01-03 |
4 |
A |
$1.53 |
$26,249 |
D/D |
17,156 |
17,156 |
|
- |
|
| Pilnik Richard D. |
Director |
– • – |
2023-01-03 |
4 |
A |
$1.53 |
$84,999 |
D/D |
55,555 |
209,882 |
|
- |
|
| Burroughs Amy L. |
Director |
– • – |
2023-01-03 |
4 |
A |
$1.53 |
$26,249 |
D/D |
17,156 |
73,288 |
|
- |
|
| Giuffre Randall Michael |
Director |
– • – |
2022-12-09 |
4 |
B |
$1.43 |
$53,023 |
D/D |
37,079 |
260,225 |
2.39 |
20% |
|
| Giuffre Randall Michael |
Director |
– • – |
2022-12-08 |
4 |
B |
$1.40 |
$28,000 |
D/D |
20,000 |
223,146 |
2.39 |
20% |
|
| Giuffre Randall Michael |
Director |
– • – |
2022-12-07 |
4 |
B |
$1.40 |
$31,604 |
D/D |
22,574 |
203,146 |
2.39 |
23% |
|
| Giuffre Randall Michael |
Director |
– • – |
2022-12-06 |
4 |
B |
$1.35 |
$3,105 |
D/D |
2,300 |
180,572 |
2.31 |
21% |
|
| Pilnik Richard D. |
Director |
– • – |
2022-12-05 |
4 |
B |
$1.39 |
$48,493 |
D/D |
35,000 |
154,327 |
2.39 |
24% |
|
67 Records found
|
|
Page 1 of 3 |
|
|
0.09 (3.59%) 
